Literature DB >> 4077883

The interface of various glasses and glass ceramics with a bony implantation bed.

U Gross, V Strunz.   

Abstract

Basing on histomorphological evaluations and morphometrical quantifications in a standardized model experiment, a comparison is made between the reactions of skeletal tissues to various glasses, glass-ceramics and enamels. On the surface of these so-called reactive biomaterials either a direct bonding to mineralized bone or also different amounts of osteoid or chondroid tissue formation can be observed, depending on the composition of the material. It is shown that the solubility of the glasses cannot directly be related to the reactivity and the resulting bone bonding; bone binds only to glasses with a controlled release of constituents and which exhibit a seam of extracellular matrix on their surface, in which normal primary mineralization can occur; the release of constituents such as Al2O3, Ta2O5, ZrO2, or phosphates from the material can inhibit this normal mineralization and the transformation of chondroid tissue to bone; if connective tissue instead of bone is present at the interface (either primarily or after bone remodelling), the dissolution (or corrosion) of the material may be no longer controllable, and the tissue reacts with a continuous inflammatory response to the corrosion products.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4077883     DOI: 10.1002/jbm.820190308

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  11 in total

1.  A new composite made of polyurethane and glass ceramic in a loaded implant model: a biomechanical and histological analysis.

Authors:  A Ignatius; K Unterricker; K Wenger; M Richter; L Claes; P Lohse; H Hirst
Journal:  J Mater Sci Mater Med       Date:  1997-12       Impact factor: 3.896

2.  Granule size and composition of bioactive glasses affect osteoconduction in rabbit.

Authors:  N C Lindfors; A J Aho
Journal:  J Mater Sci Mater Med       Date:  2003-04       Impact factor: 3.896

3.  The story of Bioglass.

Authors:  Larry L Hench
Journal:  J Mater Sci Mater Med       Date:  2006-11-22       Impact factor: 3.896

4.  Effect of glass ceramic and titanium implants on primary calcification during rat tibial bone healing.

Authors:  Z Schwartz; D Amir; B D Boyan; D Cochavy; C M Mai; L D Swain; U Gross; J Sela
Journal:  Calcif Tissue Int       Date:  1991-11       Impact factor: 4.333

5.  Surface modification of titanium implants using bioactive glasses with air abrasion technologies.

Authors:  Garrit Koller; Richard J Cook; Ian D Thompson; Timothy F Watson; Lucy Di Silvio
Journal:  J Mater Sci Mater Med       Date:  2007-06-12       Impact factor: 3.896

6.  In vitro apatite formation on nano-crystalline titania layer aligned parallel to Ti6Al4V alloy substrates with sub-millimeter gap.

Authors:  Satoshi Hayakawa; Yuko Matsumoto; Keita Uetsuki; Yuki Shirosaki; Akiyoshi Osaka
Journal:  J Mater Sci Mater Med       Date:  2015-05-20       Impact factor: 3.896

7.  Hydroxyapatite-glass composite as a bone substitute in large metaphyseal cavities in rabbits.

Authors:  E A Suominen; A J Aho; J Juhanoja; A Yli-Urpo
Journal:  Int Orthop       Date:  1995       Impact factor: 3.075

8.  Modulation of matrix vesicle enzyme activity and phosphatidylserine content by ceramic implant materials during endosteal bone healing.

Authors:  Z Schwartz; L D Swain; T Marshall; J Sela; U Gross; D Amir; C Muller-Mai; B D Boyan
Journal:  Calcif Tissue Int       Date:  1992-12       Impact factor: 4.333

9.  Evaluation of Alveolar Ridge Height Gained by Vertical Ridge Augmentation Using Titanium Mesh and Novabone Putty in Posterior Mandible.

Authors:  Rahul Malik; Ashish Gupta; Pankaj Bansal; Rahul Sharma; Sneha Sharma
Journal:  J Maxillofac Oral Surg       Date:  2019-05-31

10.  Kinetics and mechanisms of the conversion of silicate (45S5), borate, and borosilicate glasses to hydroxyapatite in dilute phosphate solutions.

Authors:  Wenhai Huang; Delbert E Day; Kanisa Kittiratanapiboon; Mohamed N Rahaman
Journal:  J Mater Sci Mater Med       Date:  2006-07       Impact factor: 4.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.